8 octubre 2015
A team of Ludwig Cancer Research scientists has mapped out how a mutant version of the epidermal growth factor receptor (EGFR) known as EGFRvIII specifically drives critical processes that alter the reading of the genome to fuel the growth of the brain cancer glioblastoma multiforme and — most important — how each process is linked to the other.
http://www.sciencedaily.com/releases/2015/10/151008142246.htm
